Caldwell J L, Stites D P, Fudenberg H H
J Immunol. 1975 Nov;115(5):1249-53.
The factors that prevent maternal immunologic rejection of the histoincompatible fetus are not understood. High levels of human chorionic gonadotropin (HCG) are present in the placenta, and several reports have noted suppresion of mitogen-induced lymphocyte transformation when cultures were supplemented with crude preparations of HCG. Purified HCG and multiple lots of crude HCG obtained from different suppliers were examined for their ability to suppress lymphocyte transformation produced by phytohemallutinin (PHA) or allogeneic stimulation. Crude preparations of HCG produced suppression of the lymphocyte stimulation induced by low doses of PHA, but the suppression could be overcome completely by increasing the PHA dose. The purified preparations of HCG produced no suppression of lymphocyte responses, even at the lower PHA dose. Purified HCG did not give a dose-related suppression of allogeneic lymphocyte responses, and crude lots of HCG gave highly variable results. One lot of crude HCG produced spontaneous stimulation of lymphocytes. Isoelectric focusing of HCG preparations demonstrated multiple bands, and lymphocyte suppression may be secondary to these additional unidentified proteins. The failure of pruified HCG to suppress lymphocyte responses makes it unlikely that the absence of maternal rejection of the fetus is due to high placental levels of HCG.
阻止母体对组织不相容胎儿产生免疫排斥反应的因素尚不清楚。胎盘内存在高水平的人绒毛膜促性腺激素(HCG),有几份报告指出,在培养物中添加HCG粗制品时,有丝分裂原诱导的淋巴细胞转化受到抑制。对从不同供应商处获得的纯化HCG和多批粗制HCG抑制由植物血凝素(PHA)或同种异体刺激产生的淋巴细胞转化的能力进行了检测。HCG粗制品可抑制低剂量PHA诱导的淋巴细胞刺激,但增加PHA剂量可完全克服这种抑制作用。即使在较低的PHA剂量下,纯化的HCG制品也不会抑制淋巴细胞反应。纯化的HCG不会对同种异体淋巴细胞反应产生剂量相关的抑制作用,而多批粗制HCG的结果差异很大。一批粗制HCG可自发刺激淋巴细胞。对HCG制品进行等电聚焦显示有多个条带,淋巴细胞抑制可能继发于这些额外的未鉴定蛋白质。纯化的HCG未能抑制淋巴细胞反应,这使得胎儿未被母体排斥不太可能是由于胎盘内HCG水平高所致。